Search

everythinglearnresearchcommunity

for

Search:↓

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The substance DMC helps get rid of aging cells by triggering a process that causes cell death, which could treat age-related diseases.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Melatonin helps hair grow by activating the RORα receptor in goats.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Blocking the Wnt/β‐catenin pathway can speed up wound healing, reduce scarring, and improve cartilage repair.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Certain small molecules can help regrow hair by turning on the body's cell cleanup process.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Curcumin applied to the skin can start hair growth in mice.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.